Citations with the tag: LUPUS nephritis
Results 1 - 50
- Editor�s foreword.
// Lupus; 1998, Vol. 7 Issue 9, p573Introduces a series of articles on lupus nephritis which were published in the September 1998 issue of `Lupus.'
- Mytcophenolate mofetil in lupus nephritis.
Cross, J.; Jayne, D. // Lupus; 2000, Vol. 9 Issue 9, p647Editorial. Discusses the benefits of using mycophenolate mofetil (MMF) in the treatment of lupus nephritis. Role of MMF in chronic allograft nephropathy; Role of MMF for remission induction in severe biopsy proven lupus nephritis; Description of MMF.
- Treatment of membranous lupus nephritis with prednisone, azathioprine and cyclosporin A.
Tam, L-S.; Li, E.; Szeto, C-C.; Wong, S-M.; Leung, C-B.; Lai, F.; Wong, K-C.; Lui, S-F. // Lupus; Nov2001, Vol. 10 Issue 11, p827Examines the safety and efficacy of combination therapy with prednisolone, azathioprine (AZA) and cyclosporin A (CSA) for the treatment of membranous lupus nephritis and followed the patients to see if relapses can be prevented by low dose AZA after withdrawal of CSA. Definition of non-renal...
- Cyclophosphamide therapy in a serious case of lupus nephritis during pregnancy.
Kart K�seoglu, H.; Y�cel, A.; K�nefeci, G.; �zdemir, F.; Duran, H. // Lupus; Nov2001, Vol. 10 Issue 11, p818Systemic lupus erythematosus (SLE) flare is common, and renal involvement is one of the most serious problems during pregnancy. Aggressive immunosuppressive therapy should be considered for patients with diffuse proliferative lupus nephritis. These individuals are at high risk for progression to...
- Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone.
Cort�s-Hern�ndez, J; Ordi-Ros, J; Labrador, M; Segarra, A; Tovar, J L; Balada, E; Vilardell-Tarres, M // Lupus; 2003, Vol. 12 Issue 4, p287Lupus nephritis remains a major cause of morbidity and mortality in patients with systemic lupus erythematosus. Although the renal prognosis has improved, the optimal therapeutic regime has not been definitively established, and significant challenges remain in the management of disease...
- Prognosis of lupus membranous nephritis in children.
Lau, K. K.; Jones, D. P.; Ault, B. H. // Lupus; 2007, Vol. 16 Issue 1, p70A letter to the editor is presented in response to article on membranous lupus nephritis.
- Delayed onset of systemic lupus erythematosus in patients with 'full-house' nephropathy.
Gianviti, A.; Barsotti, P.; Barbera, V.; Faraggiana, T.; Rizzoni, G. // Pediatric Nephrology; 1999, Vol. 13 Issue 8, p683Presents several case studies of glomerulopathy suggestive of lupus nephritis in children. Medical history of the patients; Details on the renal pathology of the patients; Diagnosis and treatment of the disease.
- Outcome in African-American children of neuropsychiatric lupus and lupus nephritis.
Vyas, S.; Hidalgo, G.; Baqi, N.; Von Gizyki, H.; Singh, A. // Pediatric Nephrology; Jan2002, Vol. 17 Issue 1, p45The present study reviews the course of lupus nephritis (LN) with the added complication of neuropsychiatric systemic lupus erythematosus (NPSLE) in a predominantly African-American population in order to identify the risk factors accounting for the increased morbidity and mortality in...
- Lupus nephritis in Chinese children � a territory-wide cohort study in Hong Kong.
Sik-Nin Wong; Kei-Chiu Tse; Tsz-Leung Lee; Kwok-Wai Lee; Chim, Stella; Kwok-Piu Lee; Chu, Reann; Chan, Winnie; Kwok-Wah Fong; Hui, Joannie; Li, Samantha; Pa-Shing Yeung; So-Fun Yuen; Ho, Assunta; Leung, Lettie; Luk, David; Pak-Chiu Tong; Shu-Yan Chan; Hon-Ming Cheung; Chung-Mo Chow // Pediatric Nephrology; Aug2006, Vol. 21 Issue 8, p1218A correction to the article "Lupus Nephritis in Chinese Children: A Territory-Wide Cohort Study in Hong Kong," by Sik-Nin Wong and colleagues that was published in the July 4, 2006 issue is presented.
- MMF May Decrease Binding of Immune Complexes in the Glomerular Capillary Wall.
Sik-Nin Wong; Kei-Chiu Tse; Tsz-Leung Lee; Kwok-Wai Lee; Chim, Stella; Kwok-Piu Lee; Chu, Reann; Chan, Winnie; Kwok-Wah Fong; Hui, Joannie; Li, Samantha; Pa-Shing Yeung; So-Fun Yuen; Ho, Assunta; Leung, Lettie; Luk, David; Pak-Chiu Tong; Shu-Yan Chan; Hon-Ming Cheung; Chung-Mo Chow // Kidney; Mar/Apr99, Vol. 8 Issue 2, p54Assesses the effect of mycophenolate mofetil (MMF) on proteinuria, on histologic severity of glomerulonephritis (GN) and on glomerular immunoglobin and complement deposition in a mouse model of lupus nephritis (LN). Reduction of the incidence of albuminuria; Immune-modulating effects observed...
- Short-Course, Low-Dose Cyc Pulses Induce EArly Response in Lupus.
Sik-Nin Wong; Kei-Chiu Tse; Tsz-Leung Lee; Kwok-Wai Lee; Chim, Stella; Kwok-Piu Lee; Chu, Reann; Chan, Winnie; Kwok-Wah Fong; Hui, Joannie; Li, Samantha; Pa-Shing Yeung; So-Fun Yuen; Ho, Assunta; Leung, Lettie; Luk, David; Pak-Chiu Tong; Shu-Yan Chan; Hon-Ming Cheung; Chung-Mo Chow // Kidney; May/Jun98, Vol. 7 Issue 3, p112Discusses the abstract of the research paper entitled 'Immunosuppressive therapy in lupus nephritis,' by D. D'Cruz, M.J. Cuadrado et al and published in a 1997 issue of the journal 'Clinical and Experimental Rheumatology.'
- Why do patients with lupus nephritis die?
Correia, P.; Cameron, J.S.; Lian, J.D.; Hicks, J.; Ogg, C.S.; Williams, D.G.; Chantler, C. // British Medical Journal (Clinical Research Edition); 1/12/1985, Vol. 290 Issue 6462, p126Examines the death of lupus nephritis patients in London, England. Pattern of mortality of patients; Complication of the treatment; Association between the disease and mortality rate.
- Sequential Therapies for Proliferative Lupus Nephritis.
Yee, Chee-Seng; Gordon, Caroline // New England Journal of Medicine; 6/10/2004, Vol. 350 Issue 24, p2518A letter to the editor is presented in response to the article "Sequential Therapies for Proliferative Lupus Nephritis" by Gabriel Contreras and colleagues in the March 4, 2004 issue.
- Sequential Therapies for Proliferative Lupus Nephritis.
Gelber, Allan C.; Christopher-Stine, Lisa; Fine, Derek M. // New England Journal of Medicine; 6/10/2004, Vol. 350 Issue 24, p2518A letter to the editor is presented in response to the article "Sequential Therapies for Proliferative Lupus Nephritis" by Gabriel Contreras and colleagues in the March 4, 2004 issue.
- Sequential Therapies for Proliferative Lupus Nephritis.
Farhey, Yolanda; Hess, Evelyn // New England Journal of Medicine; 6/10/2004, Vol. 350 Issue 24, p2518A letter to the editor is presented in response to the article "Sequential Therapies for Proliferative Lupus Nephritis" by Gabriel Contreras and colleagues in the March 4, 2004 issue.
- Sequential Therapies for Proliferative Lupus Nephritis.
Contreras, Gabriel; Lenz, Oliver; Roth, David // New England Journal of Medicine; 6/10/2004, Vol. 350 Issue 24, p2518A letter to the editor is presented in response to the article "Sequential Therapies for Proliferative Lupus Nephritis" by Gabriel Contreras and colleagues in the March 4, 2004 issue.
- Lupus nephritis: a challenging cause of rapidly progressive crescentic glomerulonephritis.
Sumethkul, V.; Chalermsanyakorn, P.; Changsirikulchai, S.; Radinahamed, P. // Lupus; 2000, Vol. 9 Issue 6, p424The outcomes of 32 lupus patients with rapidly progressive crescentic glomerulonephritis were studied. Lupus nephritis accounted for 51.6% (32/62) of all patients with biopsy proven rapidly progressive crescentic glomerulonephritis during a six year observation period that includes 961...
- Combination Therapy with Pulse Cyclophosphamide plus Pulse Methylprednisolone Improves Long-Term...
Illei, Gabor G.; Austin III, Howard A.; Crane, Marianna; Collins, Lee; Gourley, Mark F.; Yarboro, Cheryl H.; Vaughan, Ellen M.; Kuroiwa, Takashi; Danning, Carol L.; Steinberg, Alfred D.; Klippel, John H.; Balow, James E.; Boumpas, Dimitrios T. // Annals of Internal Medicine; 8/21/2001, Vol. 135 Issue 4, p248Defines the long-term risk and benefit of monthly treatment with boluses of methylprednisolone, cyclophosphamide, or both in patients with lupus nephritis. Proportion of patients who had doubling of serum creatine concentration; Benefit of treatment combination over pulse cyclophosphamide...
- Biomarker for interstitial inflammation.
Dhir, Varun // Kidney International; Jul2012, Vol. 82 Issue 2, p243A letter to the editor is presented in response to the article "A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies," by X. Zhang and colleagues in a 2012 issue.
- Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis.
Dhir, Varun // New England Journal of Medicine; 04/12/2001, Vol. 344 Issue 15, p1176A correction to the article "Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis," that was published in the February 1, 2001 issue is presented.
- Response to urinary protein markers in lupus nephritis: The need for concurrent calibration and discrimination statistics in predictive models.
Almeida, J. S.; Oates, J. C.; Arthur, J. M. // Kidney International; Jul2006, Vol. 70 Issue 1, p231The article presents a letter to the editor responding to a comment on the study about urinary markers in lupus nephritis.
- Urinary protein markers in lupus nephritis: The need for concurrent calibration and discrimination statistics in predictive models.
Lin, Y.-F.; Chu, P.; Lin, S.-H.; Chiu, J.-S. // Kidney International; Jul2006, Vol. 70 Issue 1, p230The article presents a letter to the editor commenting on a study on urinary protein markers in lupus nephritis.
- The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value.
Cifersk�, Hana; Hor�k, Pavel; Hermanov�, Zuzana; Ordeltov�, Marta; Zadra�il, Josef; Tich�, Tom�; �cudla, Vlastimil // Clinical Rheumatology; May2007, Vol. 26 Issue 5, p852A correction to a graph showing the levels of sCD40L in a group of patients with lupus nephritis and without lupus nephritis that was published in the journal "Clinical Rheumatology," is presented.
- Recurrent LN Does Not Always Cause Graft Loss.
Cifersk�, Hana; Hor�k, Pavel; Hermanov�, Zuzana; Ordeltov�, Marta; Zadra�il, Josef; Tich�, Tom�; �cudla, Vlastimil // Kidney; Nov/Dec98, Vol. 7 Issue 6, p254Presents an abstract of the study 'Recurrent LN Does Not Always Cause Graft Loss,' by J.H. Stone et al published in 1998.
- Earlier Rituximab Better for Lupus Nephritis Patients.
SCHIESZER, JOHN // Renal & Urology News; Feb2011, Vol. 10 Issue 2, p17The article discusses the findings of some medical experts with regard to the benefits of taking rituximab earlier in the course of the disease by lupus nephritis patients in the U.S.
- Autoimmunity: Restoring natural order.
Bordon, Yvonne // Nature Reviews Immunology; Apr2012, Vol. 12 Issue 4, p232The article discusses research being done on natural autoantibodies, which references the study "Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival," by K. Mannoor and colleagues in the March 9, 2012 issue of "Journal of Immunology."
- Arthritis Care and Research.
Bordon, Yvonne // Biomedical Market Newsletter; 5/7/2012, Vol. 21, p1The article informs that the updated guidelines for the management of lupus nephritis has been issued by American College of Rheumatology which includes identification of renal disease, recent therapies and treatment of pregnant patients with systemic lupus erythematosus.
- Novel approaches in the treatment of lupus nephritis.
Illei, G.G.; Klippel, J.H. // Lupus; 1998, Vol. 7 Issue 9, p644Lupus nephritis can be managed successfully in the majority of cases; most therapies, however, are associated with significant side-effects. Several new agents aiming at specific stages in the pathogenesis of lupus are in different phases of clinical trials. The central role of lymphocytes makes...
- Renal biopsy in lupus nephritis.
Grande, J.P.; Balow, J.E. // Lupus; 1998, Vol. 7 Issue 9, p611Renal biopsy can be extremely valuable in the management of patients with lupus nephritis. It is remarkably common to find pathological evidence of substantial nephron loss in patients with low-grade laboratory abnormalities. This is due to compensatory hypertrophy and hemodynamic adjustments...
- Lupus nephritis in Lebanon.
Uthman, I.; Muffarij, A.; Mudawar, W.; Nasr, F.; Masri, A-F. // Lupus; May2001, Vol. 10 Issue 5, p378This is a retrospective study of the clinicopathological characteristics of 50 systemic lupus erythematosus patients with nephritis who underwent a kidney biopsy and were admitted to the American University of Beirut Medical Center, in Lebanon, between 1979 and 1999. There were 43 females and...
- Letter to the Editor.
Matthews, SB; Kallarackal, G; Shortt, M; Pritchard, MH // Lupus; 2002, Vol. 11 Issue 1, p64Reports the usefulness of chemoadsorption apheresis as therapy for lupus nephritis. Background on the patient; Treatment given to the patient; Significance of the case study.
- Classes, activity and chronicity indices, and a-smooth muscle actin expression as prognostic parameters in lupus nephritis outcome.
Ravinal, R Cuan; Costa, RS; Coimbra, TM; Pastorello, MT; Coelho, EB; Dantas, M; dos Reis, MA // Lupus; 2002, Vol. 11 Issue 2, p82Renal biopsies of 86 patients with lupus nephritis were assessed according to the WHO classification, and according to activity and chronicity indices. The aim of the present study was to correlate clinical, and histological features (WHO class, activity and chronicity indices, and a-SM actin...
- Lupus nephritis: assessing the evidence, considering the future.
Isenberg, D.; Lesavre, P. // Lupus; 2007, Vol. 16 Issue 3, p210The article discusses various papers published within the issue, including Fr�d�ric Houssiau's review on the use of cyclophosphamide in managing lupus nephritis for the past 30 years, Dr. Davis Jayne about misconceptions on the management of lupus nephritis, and Professor Matthias Schneider...
- Methylprednisolone pulse therapy in Japanese children with severe lupus nephritis.
Tanaka, H.; Tateyama, Takashi; Waga, Shinobu // Pediatric Nephrology; Oct2001, Vol. 16 Issue 10, p817Six Japanese children with severe lupus nephritis received prompt initiation of methylprednisolone pulse therapy (MPT). After three courses of MPT, oral prednisolone combined with a 12-week course of oral cyclophosphamide was given and prednisolone was tapered. At presentation, urine protein...
- Stimulated Renin Release May Be Central to Pathogenesis of HHD.
Tanaka, H.; Tateyama, Takashi; Waga, Shinobu // Kidney; Sep/Oct99, Vol. 8 Issue 5, p200Discusses an abstract of the article, entitled `Mycophenolate mofetil therapy in lupus nephritis: Clinical observations,' by M.A. Dooley, F.G. Cosio, P.H. Nachman and others, published in the 1999 'Journal of American Social Nephrology'.
- MMF: An Alternative to Cyclophosphamide for Nephritis.
Tanaka, H.; Tateyama, Takashi; Waga, Shinobu // Kidney; Sep/Oct99, Vol. 8 Issue 5, p201Discusses an abstract of the article, entitled `Mycophenolate mofetil therapy in lupus nephritis: Clinical observations,' by M.A. Dooley, F.G. Cosio, P.H. Nachman and others.
- Tubular lesions strongly predict decline in renal function in lupus nephritis.
Daniel, L.; Sichez, H.; Giorgi, R. // Kidney; Jul/Aug2002, Vol. 11 Issue 4, p158Deals with a study which assessed the prognostic value of tubular lesions and expression of cell adhesion molecules. Methodology used in the study; Results and conclusion.
- Chronic Active Hepatits with Lupus Nephritis.
Benner, E. Jack; Gourley, Richard T.; Cooper Jr., Robert A.; Benson, John A. // Annals of Internal Medicine; Feb68, Vol. 68 Issue 2, p405Presents two case studies of chronic active hepatitis with lupus nephritis. Analysis of a case of chronic active hepatitis with renal lesion of systemic lupus erythromatosus; Examination of a case of xanthomatous biliary cirrhosis with lupus nephritis.
- Mycophenolate Mofetil or Intravenous Cyclophosphamide in Lupus Nephritis.
Karassa, Fotini B. // New England Journal of Medicine; 2/16/2006, Vol. 354 Issue 7, p764A letter to the editor is presented in response to the article "Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis," by E.M. Ginzler, M.A. Dooley and C. Aranow in the November 25, 2005 issue.
- Mycophenolate Mofetil or Intravenous Cyclophosphamide in Lupus Nephritis.
Killen, John Paul // New England Journal of Medicine; 2/16/2006, Vol. 354 Issue 7, p764A letter to the editor is presented in response to the article "Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis," by E.M. Ginzler, M.A. Dooley and C. Aranow in the November 25, 2005 issue.
- Mycophenolate Mofetil or Intravenous Cyclophosphamide in Lupus Nephritis.
Ginzler, Ellen M.; Dooley, Mary Anne; Kim, Mimi Y. // New England Journal of Medicine; 2/16/2006, Vol. 354 Issue 7, p764A response by Ellen M. Ginzler, Mary Anne Dooley and Mimi Y. Kim to a letter to the editor in response to their article "Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis" in the November 25, 2005 issue is presented.
- Rapidly progressive lupus glomerulonephritis and concomitant microangiopathy in an adolescent.
Blake, JS; Butani, L // Lupus; 2002, Vol. 11 Issue 8, p533We describe our experience managing a 16-year-old girl with systemic lupus erythematosus (SLE) who presented concomitantly with rapidly progressive glomerulonephritis (RPGN) and a thrombotic microangiopathic hemolytic anemia (TMAHA). Her renal biopsy showed evidence of diffuse proliferative...
- MMF Beats Azathioprine For LN.
Blake, JS; Butani, L // Renal & Urology News; Feb2012, Vol. 11 Issue 2, p27The article reports on the effectiveness of mycophenolate mofetil (MMF) as maintenance therapy for patients with active lupus nephritis.
- Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.
Zoja, Carla; Benigni, Ariela; Noris, Marina; Corna, Daniela; Casiraghi, Federica; Pagnoncelli, Marcella; Rottoli, Daniela; Abbate, Mauro; Remuzzi, Giuseppe // Kidney International; Aug2001, Vol. 60 Issue 2, p653Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis. Background. Approaches to the treatment of lupus nephritis include immunosuppressants associated with anti-inflammatory drugs, mainly steroids, which, however, cause major side effects....
- Lupus Nephritis and Other Autoimmune Features in Patients with Diabetes Mellitus Due to Autoantibody to Insulin Receptors.
Tsokos, George C.; Gorden, Phillip; Antonovych, Tatiana; Wilson, Curtis B.; Balow, James E. // Annals of Internal Medicine; Feb85, Vol. 102 Issue 2, p176Presents information on a study which determined lupus nephritis and the frequency of various autoimmune features in patients with diabetes mellitus. Methodology; Results; Discussion.
- Correlation versus agreement in two methods for urinary protein quantification in lupus nephritis.
Restrepo-Escobar, M // Lupus; Oct2012, Vol. 21 Issue 11, p1259A letter to the editor is presented in response to the article "Correlation of 24-hour urinary protein quantification with spot urine protein: creatinine ratio in lupus nephritis," by H. E. Matar and colleagues in the 2012 issue.
- Therapeutic options for critically ill patients suffering from progressive lupus nephritis or Goodpasture's syndrome.
Merkel, Frank; Netzer, Kai-Olaf; Gross, Oliver; Marx, Martin; Weber, Manfred // Kidney International Supplement; Feb98, Issue 64, pS-31Examines the therapeutic options for critical ill patients with progressive lupus nephritis or Goodpasture's syndrome. Difference between systemic lupus erythematosus and Goodpasture's syndrome; Common feature of rapid declining renal function and pulmonary hemorrhage; Importance of early...
- Cyclophosphamide in Lupus Nephritis: A Controlled Trial.
Steinberg, Alfred D.; Kaltreider, H. Benfer; Staples, Parker J.; Goetzl, Edward J.; Talal, Norman; Decker, John L. // Annals of Internal Medicine; Aug71, Vol. 75 Issue 2, p165Focuses on a therapeutic trial comparing the use of oral cyclophosphamide and placebo in women with lupus nephritis. Distinction of groups of patients with lupus renal disease; Attributes of patients who participated in the trial; Criteria for the improvement or deterioration of patients.
- Plasmapheresis Does Not Increase the Risk for Infection in Immunosuppressed Patients with Severe Lupus Nephritis.
Pohl, Marc A.; Lan, Shu-Ping; Berl, Tomas // Annals of Internal Medicine; 6/1/91, Vol. 114 Issue 11, p924Deals with a study which determined whether plasmapheresis increases the risk for infection in immunosuppressed patients with severe lupus nephritis. Patients and methods; Infection in various phases of the study; Interpretation of the research findings.
- Semi-quantitative evaluation of gallium-67 scintigraphy in lupus nephritis.
Lin, Wan-Yu; Hsieh, Jih-Fang; Tsai, Shih-Chuan; Lan, Joung-Liang; Cheng, Kai-Yuan; Wang, Shyh-Jen // European Journal of Nuclear Medicine; 2000, Vol. 27 Issue 11, p1626Abstract. Within nuclear medicine there is a trend towards quantitative analysis. Gallium renal scan has been reported to be useful in monitoring the disease activity of lupus nephritis. However, only visual interpretation using a four-grade scale has been performed in previous studies, and this...
